Bionomics Limited (OTCMKTS:BNOEF – Get Rating) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 116,500 shares, a decrease of 34.9% from the November 30th total of 178,900 shares. Based on an average daily trading volume, of 31,400 shares, the days-to-cover ratio is currently 3.7 days.
Bionomics Stock Performance
Shares of Bionomics stock opened at $0.03 on Friday. The firm has a fifty day moving average of $0.04 and a two-hundred day moving average of $0.04. Bionomics has a one year low of $0.01 and a one year high of $0.09.
Get Bionomics alerts:Bionomics Company Profile
(Get Rating)
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.Read More
- Get a free copy of the StockNews.com research report on Bionomics (BNOEF)
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
- 3 High-Yield Dividend Stocks to Hold for the Long Haul
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.